Ohio Recalls Ozone Cannabis Gummies Over Missing THC Symbols

Ohio's Division of Cannabis Control ordered a Class II recall of Ozone-branded cannabis gummies last Friday after inspectors found individual servings lacked the state-mandated universal THC symbol.

The recall affects multiple varieties of Ozone Soft Chews manufactured by Marichron Pharma LLC and packaged between September 5 and late December. While the product packaging displayed proper THC warnings, each individual gummy inside failed to carry the required symbol—a violation of Ohio's consumer safety regulations.

Class II recalls indicate a low risk of serious health consequences but represent regulatory violations that could confuse or mislead consumers. In Ohio's adult-use market, which launched in August 2024, every piece of edible cannabis must be individually marked to prevent accidental consumption, particularly in households with children.

The Labeling Requirements

Ohio law requires that each serving of a cannabis edible—not just the outer package—display the universal THC symbol. The rule aims to make every piece of cannabis-infused food immediately identifiable, even after it's removed from its original container.

This isn't just bureaucratic red tape. States with mature cannabis markets have documented cases of accidental ingestion when edibles look identical to regular candy. Colorado, which pioneered individual serving requirements in 2016, saw a 25% drop in pediatric emergency room visits after implementing similar rules.

Marichron Pharma, which operates as part of the Ascend Wellness Holdings portfolio, hasn't issued a public statement about the recall. The DCC identified the issue during routine compliance inspections of licensed dispensaries.

What Consumers Should Do

Anyone who purchased Ozone Soft Chews between early September and now should check their products. The recalled items can be returned to the dispensary where they were purchased for a full refund or exchange.

The DCC maintains a public database of all product recalls, which dispensaries are required to check before completing sales. But products already in consumers' homes won't automatically disappear—that's why the division sent direct notifications to registered patients and adult-use purchasers who bought the affected batches.

Ohio's cannabis market generated $434 million in sales during its first four months of adult-use operation. With that growth comes increased scrutiny of compliance issues that were less visible during the medical-only era.

Industry Impact

This recall highlights the operational challenges manufacturers face as they scale up production for the adult-use market. Marichron Pharma isn't alone—Ohio has issued 14 product recalls since adult-use sales began, ranging from labeling errors to potency discrepancies.

For consumers, the silver lining is that the system is working. Regulators caught the violation before any adverse events were reported, and the recall process moved quickly.

The DCC hasn't indicated whether Marichron Pharma will face additional penalties beyond the mandatory recall. Ohio's cannabis control laws allow for fines and license suspensions in cases of repeated violations, though first-time labeling errors typically result in corrective action orders rather than harsher sanctions.

Dispensaries carrying Ozone products have pulled the affected batches and are working with the manufacturer to verify that replacement inventory meets all labeling requirements before restocking shelves.

This article is based on original reporting by ganjapreneur.com.